(PDF) Identification of a New Class of Natural Product MDM2

Identification of a New Class of Natural Product MDM2 Inhibitor: In Vitro and in Vivo Anti-Breast Cancer Activities and Target Validation

Oncotarget - United States

doi 10.18632/oncotarget.3098

Full Text

Abstract

Available in full text

Categories

Date

January 11, 2015

Authors

Jiang-Jiang Qin

Sukesh Voruganti

Publisher

Impact Journals, LLC

Related search

Suppression of FOXM1 Activities and Breast Cancer Growth in Vitro and in Vivo by a New Class of Compounds

npj Breast Cancer

Nuclear Medicine

English

Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer

Scientific Reports

Multidisciplinary

English

Identification of a New Class of MDM2 Inhibitor That Inhibits Growth of Orthotopic Pancreatic Tumors in Mice

Gastroenterology

Gastroenterology

English

Evaluation of the in Vivo Anti-Inflammatory and Analgesic and in Vitro Anti-Cancer Activities of Curcumin and Its Derivatives

Natural Product Communications

Alternative Medicine

English

Pharmacophore Modeling for Identification of Anti-Igf-1r Drugs and In-Vitro Validation of Fulvestrant as a Potential Inhibitor

Multidisciplinary

English

In Vitro and in Vivo Anti-Inflammatory Activities of Mesua Ferrea Linn

International Journal of Pharmacognosy and Phytochemical Research

English

Antitumor Activity of the Selective Cyclooxygenase-2 Inhibitor, Celecoxib, on Breast Cancer in Vitro and in Vivo

Cancer Cell International

Cancer Research

English

Anti-Tumoral Effects of a Trypsin Inhibitor Derived From Buckwheat in Vitro and in Vivo

Molecular Medicine Reports

Molecular Biology

Cancer Research

Molecular Medicine

English

In Vitro and in Vivo Anti-Trypanosoma Brucei Activities of Phenazinomycin and Related Compounds

Journal of Antibiotics

English